Bisphosphonates in RSD: Treating Bone Pain and Osteoporosis
Reflex Sympathetic Dystrophy (RSD), now usually called Complex Regional Pain Syndrome (CRPS), can affect nerves, skin, muscles and bones after an injury, operation or period of immobilisation. Some people develop marked bone pain and reduced bone density in the affected hand, foot, arm or leg. This can make ordinary movement feel unsafe and may complicate rehabilitation.
Bisphosphonates are medicines best known for treating osteoporosis, but they may also help selected people with CRPS-related bone pain. Their role depends on the stage of the condition, scan results, kidney function, dental health and other treatments already being used. They should be prescribed and monitored by a qualified clinician rather than started as a self-treatment.
How RSD Affects Bone
CRPS can disturb the normal balance between bone formation and bone breakdown. Reduced use of a limb, inflammation and changes in local blood flow may contribute to patchy osteopenia or osteoporosis. A person may have pain that seems far greater than expected from the original injury, along with swelling, stiffness and sensitivity to touch.
X-rays may show a speckled or “washed-out” appearance in the bones, although early images can be normal. A bone scan or dual-energy X-ray absorptiometry (DEXA) scan may provide additional information, but scan findings must be interpreted alongside the physical examination. Changes in skin temperature changes can support the clinical picture without proving that CRPS is present.
What Bisphosphonates Do
Bisphosphonates attach to bone mineral and reduce the activity of osteoclasts, the cells that break down bone. This can slow bone loss and, in some cases, reduce the inflammatory bone pain associated with CRPS. Research has examined oral alendronate and medicines given by infusion, including pamidronate, neridronate and zoledronic acid.
Evidence is encouraging for certain patients, particularly when symptoms are relatively recent and bone changes are prominent, but it is not uniform. Studies have differed in drug, dose, treatment duration and patient selection. A bisphosphonate may be considered as part of a broader plan, rather than as a universal treatment for every person with RSD.
Deciding Whether Treatment Fits
A doctor will usually review the history of the injury, pain pattern, swelling, colour and temperature changes, sweating, movement, strength and skin sensitivity. Other causes of pain and bone loss may need to be excluded, including infection, arthritis, nerve compression, fracture, vascular disease and medication-related osteoporosis.
The treatment decision may involve a GP, pain specialist, rheumatologist, endocrinologist or rehabilitation physician. In Australia, a patient might begin with a local GP before referral to a public hospital pain clinic or a private specialist. Waiting times can vary, especially outside Sydney, Melbourne, Brisbane and other major centres, so a clear interim plan for movement and symptom control is important.
Medicines And Administration
Oral alendronate is commonly used for osteoporosis and must be taken with plain water according to precise instructions. The person generally remains upright for a specified period and waits before eating or taking other medicines. These steps reduce irritation of the oesophagus and improve absorption.
Intravenous pamidronate or zoledronic acid may be discussed when oral treatment is unsuitable or when a specialist believes an infusion is appropriate. Neridronate has evidence in CRPS research but availability and approval arrangements differ between countries. In Australia, use for CRPS may be outside the standard approved indication, and Pharmaceutical Benefits Scheme (PBS) coverage can depend on the medicine and the reason it is prescribed.
Safety And Monitoring
Bisphosphonates can cause indigestion, reflux, nausea, muscle aches or a temporary flu-like reaction after infusion. More serious concerns include low calcium levels, kidney problems, rare jaw osteonecrosis and very rare atypical thigh-bone fractures. The risk profile changes with dose, duration, dental disease, kidney function and other medicines.
Before treatment, the clinician may check kidney function, calcium, vitamin D status and oral health. A dental review is especially sensible when invasive dental work is likely, though necessary dental care should not be postponed without medical advice. Seek prompt care for severe muscle spasms, facial tingling, reduced urine output, jaw swelling, exposed jaw bone or new thigh or groin pain.
Combining Treatment With Rehabilitation
A bisphosphonate cannot restore normal movement by itself. Graded physiotherapy, occupational therapy, desensitisation, pacing and carefully planned strengthening remain central to recovery and function. The aim is to increase safe use of the limb without repeatedly provoking a major flare.
Pain relief may also include simple analgesics, neuropathic pain medicines, topical treatments or psychological support, depending on the individual. Australian pain services may use a multidisciplinary approach, while people in regional areas may combine local physiotherapy with telehealth appointments. A pharmacist at a community chemist can help check administration instructions and potential medicine interactions.
Practical Steps To Discuss With Your Clinician
Keeping a record of pain, swelling, walking or hand function, sleep, medicine effects and flare triggers can make appointments more productive. Bone density results should be interpreted in context, since a low DEXA score does not automatically mean that a bisphosphonate will improve CRPS pain.
Discuss the following points before treatment begins:
- Whether the diagnosis is CRPS/RSD and whether another bone or nerve condition needs investigation
- Whether X-rays, a DEXA scan, blood tests or other imaging would change the treatment decision
- Which bisphosphonate, route and duration are suitable for your symptoms and health history
- Kidney function, calcium, vitamin D, pregnancy considerations and current medicines
- Dental problems, planned extractions, implants or other invasive procedures
- How pain relief will be assessed and when physiotherapy or occupational therapy should progress
- Which symptoms require urgent review during or after treatment
Bisphosphonates may be useful when CRPS includes significant bone pain or regional bone loss, but benefits and risks need individual assessment. Use reliable information to prepare for a conversation with your GP or specialist, and take your medication list, scan reports and dental history to the appointment. Prompt, coordinated care can help protect bone health while keeping rehabilitation focused on restoring practical function.